Losanorm-H 50mg 10 Tablets

babies: nil. lactating mothers: it is contraindicated due to studies that have shown evidence of medicine in breast milk.
it causes toxicity to the baby. pregnancy: it is contraindicated in pregnancy.
seek doctor advice before using this medication. driving: hydrochlorothiazide and losartan potassium tablet may cause dizziness and drowsiness.
do not drive if these symptoms occur. alcohol: safe if prescribed by your doctor.
liver: hydrochlorothiazide and losartan potassium tablet should be used in caution with patients suffering from liver disease. you may require dosage adjustment and regular monitoring of liver function.
seek doctor advice before using this medication. hydrochlorothiazide and losartan potassium tablet is not recommended in severe liver disease. kidney: hydrochlorothiazide and losartan potassium tablet should be used in caution with patients suffering from kidney disease.
you may require dosage adjustment and regular monitoring of liver function. seek doctor advice before using this medication.
.

Fatigue Hypoglycemia Chest pain Cough Hypotension Anorexia Epigastric distress Hypokalemia Phototoxicity Diarrhea Dizziness Nausea Thrombocytopenia.

LOSANORM H is a calcium channel blocker that relaxes blood vessels by blocking the hormone angiotensin. it is a diuretic that excretes excess water and electrolytes from the body and through urine.
it also works by relaxing blood vessels and improving blood flow..

If you miss a dose, take LOSANORM H as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• consume plenty of water and keep yourself well-hydrated while on LOSANORM H • it could lead to more frequent urination. to avoid waking up to urinate, take it at least 4 hours before bedtime • it may cause an increase in potassium levels in the blood.
avoid foods that are high in potassium, such as bananas, and broccoli • pregnancy needs to be avoided for a period of 6 months from the stop of the last dose. as it may cause harmful effects to the baby.

contraindicated • (hydrochlorothiazide + losartan potassium) + aliskiren: concurrent use leads to reduction in the the effects of aliskiren by losartan. the use of aliskiren with arbs is contraindicated in diabetic patients; avoid coadministration with arbs if gfr is low.
coadministration of arbs with drugs that affect raas may increase the risk of renal impairment (including acute renal failure) and cause loss of antihypertensive effect in patients who are elderly, volume-depleted (including those on diuretic therapy), or have compromised renal function. on a regular basis, check the renal function. serious • (hydrochlorothiazide + losartan potassium) + abametapir: concurrent use leads to decrease in levels of losartan by affecting hepatic/intestinal enzyme cyp3a4 metabolism • (hydrochlorothiazide + losartan potassium) + benazepril: concurrent use leads to increased toxicity of either of them by pharmacodynamic synergism leading to increase risk of hypotension, hyperkalemia and renal impairment • (hydrochlorothiazide + losartan potassium) + lithium: concurrent use leads to increased toxicity of lithium by decreasing its renal clearance monitor closely • (hydrochlorothiazide + losartan potassium) + acebutolol: concurrent use leads to increased serum potassium levels due to pharmacodynamic synergism • (hydrochlorothiazide + losartan potassium) + albiglutide: concurrent use leads to increased effects of albigutide by losartan as it enhances hypoglycemic effects of albiglutide.